Abemaciclib with Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update
ASCO Guidelines
00:00
Balancing Benefits and Risks in Breast Cancer Treatment Recommendations
This chapter explores updated recommendations for the use of adjuvant abemaciclib in high-risk early breast cancer treatment. It highlights the need for careful consideration of treatment benefits versus potential toxicities to guide clinical decision-making.
Play episode from 05:02
Transcript
